|
業務類別
|
Biotechnology |
|
業務概覽
|
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others. |
| 公司地址
| 245 First Street, 18th Floor, Cambridge, MA, USA, 02142 |
| 電話號碼
| +1 857 327-8778 |
| 傳真號碼
| +1 617 890-6595 |
| 公司網頁
| https://www.cyclerion.com |
| 員工數量
| 1 |
| Ms. Regina Margaret Graul, PhD |
Director, President and Chief Executive Officer |
美元 390.83K |
31/03/2026 |
| Ms. Rhonda M. Chicko |
Chief Financial Officer and Principal Accounting Officer |
美元 249.90K |
31/03/2026 |
|
|
| Mr. Michael J. Higgins |
Independent Director |
31/03/2026 |
| Ms. Regina Margaret Graul, PhD |
Director, President and Chief Executive Officer |
31/03/2026 |
| Dr. Errol B. De Souza,PhD |
Chairman of the Board |
31/03/2026 |
| Dr. Peter M. Hecht, PhD |
Director |
31/03/2026 |
| Dr. Steven E. Hyman, M.D. |
Independent Director |
31/03/2026 |
| Dr. Dina Katabi, M.S.,PhD |
Independent Director |
31/03/2026 |
|
|
|
|
